These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19663740)

  • 1. Role of membrane transporters in the safety profile of drugs.
    Lee EJ; Lean CB; Limenta LM
    Expert Opin Drug Metab Toxicol; 2009 Nov; 5(11):1369-83. PubMed ID: 19663740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug transporters in drug efficacy and toxicity.
    DeGorter MK; Xia CQ; Yang JJ; Kim RB
    Annu Rev Pharmacol Toxicol; 2012; 52():249-73. PubMed ID: 21942630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and/or non-genetic causes for inter-individual and inter-cellular variability in transporter protein expression: implications for understanding drug efficacy and toxicity.
    Koo SH; Lo YL; Yee JY; Lee EJ
    Expert Opin Drug Metab Toxicol; 2015; 11(12):1821-37. PubMed ID: 26489003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transporters in absorption, distribution, and elimination.
    Scherrmann JM
    Chem Biodivers; 2009 Nov; 6(11):1933-42. PubMed ID: 19937831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of hepatic transporters in drug elimination.
    Funk C
    Expert Opin Drug Metab Toxicol; 2008 Apr; 4(4):363-79. PubMed ID: 18433342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.
    Leslie EM; Deeley RG; Cole SP
    Toxicol Appl Pharmacol; 2005 May; 204(3):216-37. PubMed ID: 15845415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transporters in drug development and clinical pharmacology.
    Giacomini KM; Huang SM
    Clin Pharmacol Ther; 2013 Jul; 94(1):3-9. PubMed ID: 23778703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease-Associated Changes in Drug Transporters May Impact the Pharmacokinetics and/or Toxicity of Drugs: A White Paper From the International Transporter Consortium.
    Evers R; Piquette-Miller M; Polli JW; Russel FGM; Sprowl JA; Tohyama K; Ware JA; de Wildt SN; Xie W; Brouwer KLR;
    Clin Pharmacol Ther; 2018 Nov; 104(5):900-915. PubMed ID: 29756222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcellular drug distribution: mechanisms and roles in drug efficacy, toxicity, resistance, and targeted delivery.
    Li Q; Zhou T; Wu F; Li N; Wang R; Zhao Q; Ma YM; Zhang JQ; Ma BL
    Drug Metab Rev; 2018 Nov; 50(4):430-447. PubMed ID: 30270675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transporter-mediated drug delivery: recent progress and experimental approaches.
    Sai Y; Tsuji A
    Drug Discov Today; 2004 Aug; 9(16):712-20. PubMed ID: 15341785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Modeling of Drug-Transporter Interactions-An International Transporter Consortium Perspective.
    Schlessinger A; Welch MA; van Vlijmen H; Korzekwa K; Swaan PW; Matsson P
    Clin Pharmacol Ther; 2018 Nov; 104(5):818-835. PubMed ID: 29981151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics.
    Mannermaa E; Vellonen KS; Urtti A
    Adv Drug Deliv Rev; 2006 Nov; 58(11):1136-63. PubMed ID: 17081648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo approaches to characterize transporter-mediated disposition in drug discovery.
    Feng B; Varma MV; Costales C; Zhang H; Tremaine L
    Expert Opin Drug Discov; 2014 Aug; 9(8):873-90. PubMed ID: 24857286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efflux transporter mRNA expression profiles in differentiating JEG-3 human choriocarcinoma cells as a placental transport model.
    Ikeda K; Yamasaki K; Homemoto M; Yamaue S; Ogawa M; Nakao E; Fukunaga Y; Nakanishi T; Utoguchi N; Myotoku M; Hirotani Y
    Pharmazie; 2012 Jan; 67(1):86-90. PubMed ID: 22393837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Considerations in the design and development of transport inhibitors as adjuncts to drug therapy.
    Dantzig AH; de Alwis DP; Burgess M
    Adv Drug Deliv Rev; 2003 Jan; 55(1):133-50. PubMed ID: 12535578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of excipients on transporter mediated absorption.
    Goole J; Lindley DJ; Roth W; Carl SM; Amighi K; Kauffmann JM; Knipp GT
    Int J Pharm; 2010 Jun; 393(1-2):17-31. PubMed ID: 20417699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of ATP-binding cassette transporters for brain pharmacotherapies.
    Hermann DM; Bassetti CL
    Trends Pharmacol Sci; 2007 Mar; 28(3):128-34. PubMed ID: 17275929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transporter-mediated drug interaction].
    Komori H; Tamai I
    Nihon Yakurigaku Zasshi; 2014 May; 143(5):243-8. PubMed ID: 24813795
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of Drug Transporters on Pharmacological Responses and Safety.
    Liu CX; Yi XL; Fan HR; Wu WD; Zhang X; Xiao XF; He X
    Curr Drug Metab; 2015; 16(9):732-52. PubMed ID: 26630905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox).
    Szakács G; Váradi A; Ozvegy-Laczka C; Sarkadi B
    Drug Discov Today; 2008 May; 13(9-10):379-93. PubMed ID: 18468555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.